Xeris Biopharma Holdings (XERS) Goodwill & Intangibles (2021 - 2025)
Xeris Biopharma Holdings' Goodwill & Intangibles history spans 5 years, with the latest figure at $110.9 million for Q4 2025.
- For the quarter ending Q4 2025, Goodwill & Intangibles fell 8.9% year-over-year to $110.9 million, compared with a TTM value of $110.9 million through Dec 2025, down 8.9%, and an annual FY2025 reading of $110.9 million, down 8.9% over the prior year.
- Goodwill & Intangibles for Q4 2025 was $110.9 million at Xeris Biopharma Holdings, down from $113.6 million in the prior quarter.
- The five-year high for Goodwill & Intangibles was $154.3 million in Q4 2021, with the low at $110.9 million in Q4 2025.
- Average Goodwill & Intangibles over 5 years is $132.6 million, with a median of $132.6 million recorded in 2023.
- Year-over-year, Goodwill & Intangibles fell 7.03% in 2022 and then fell 8.9% in 2025.
- Tracing XERS's Goodwill & Intangibles over 5 years: stood at $154.3 million in 2021, then fell by 7.03% to $143.5 million in 2022, then dropped by 7.56% to $132.6 million in 2023, then dropped by 8.18% to $121.8 million in 2024, then fell by 8.9% to $110.9 million in 2025.
- Per Business Quant, the three most recent readings for XERS's Goodwill & Intangibles are $110.9 million (Q4 2025), $113.6 million (Q3 2025), and $116.4 million (Q2 2025).